SAREPTA THERAPEUTICS INC (SRPT) Stock Balance Sheet
NASDAQ:SRPT • US8036071004
Current stock price
21.73 USD
-0.42 (-1.9%)
At close:
21.8533 USD
+0.12 (+0.57%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 801.28M | 1.10B | 428.43M | 966.80M | 2.12B | |||
| Marketable Securities | 138.37M | 251.78M | 1.25B | 1.02B | 0.00 | |||
| Receivables | 519.61M | 649.73M | 439.71M | 259.70M | 171.60M | |||
| Inventories | 914.74M | 749.96M | 322.86M | 204.00M | 186.20M | |||
| Other Current Assets | 163.93M | 318.98M | 140.52M | 104.80M | 130.40M | |||
| Total Current Assets | 2.54B | 3.07B | 2.58B | 2.56B | 2.60B | |||
| Non-Current Assets | ||||||||
| PPE Net | 470.62M | 488.65M | 357.11M | 245.00M | 236.70M | |||
| Investments And Advances | 10.57M | 136.87M | 6.53M | 31.30M | 34.90M | |||
| Intangibles | 28.95M | 26.89M | 29.62M | 7.60M | 14.20M | |||
| Other Non-Current Assets | 301.63M | 237.30M | 291.99M | 286.60M | 258.10M | |||
| Total Non-Current Assets | 811.76M | 889.71M | 685.25M | 570.50M | 543.90M | |||
| TOTAL ASSETS | 3.35B | 3.96B | 3.26B | 3.13B | 3.15B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 105.48M | N/A | N/A | |||
| Accrued Expenses | 248.58M | 260.24M | 219.00M | 353.20M | 224.60M | |||
| Accounts Payable | 280.84M | 214.44M | 164.92M | 95.90M | 76.70M | |||
| Other Current Liabilities | 565.87M | 257.00M | 164.26M | 170.50M | 151.40M | |||
| Total Current Liabilities | 1.10B | 731.68M | 653.66M | 619.60M | 452.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 828.97M | 1.14B | 1.13B | 1.54B | 1.10B | |||
| Other Non-Current Liabilities | 284.82M | 566.62M | 619.07M | 579.50M | 670.40M | |||
| Total Non-Current Liabilities | 1.11B | 1.70B | 1.75B | 2.12B | 1.77B | |||
| TOTAL LIABILITIES | 2.21B | 2.44B | 2.41B | 2.74B | 2.22B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -4.88B | -4.21B | -4.45B | -3.91B | -3.21B | |||
| Additional Paid In Capital | 6.04B | 5.74B | 5.30B | 4.30B | 4.13B | |||
| Common Shares | 11.00K | 10.00K | 9.00K | 0.00 | 0.00 | |||
| Treasury Stock | -25.26M | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 272.00K | -218.00K | 918.00K | -1.70M | 0.00 | |||
| Shares Outstanding | 104.96M | 96.90M | 93.73M | 88.00M | 87.10M | |||
| Tangible Book Value per Share | 10.59 | 15.49 | 8.85 | 4.29 | 10.49 | |||
| Total Shareholders' Equity | 1.14B | 1.53B | 859.34M | 385.00M | 928.00M | |||
| TOTAL LIABILITIES AND EQUITY | 3.35B | 3.96B | 3.26B | 3.13B | 3.15B | |||
| Statistics | ||||||||
| Debt/Equity | 0.73 | 0.74 | 1.32 | 4.01 | 1.18 | |||
| Current Ratio | 2.32 | 4.20 | 3.95 | 4.13 | 5.75 | |||
| Return On Assets (ROA) | -21.30% | 5.94% | -16.42% | -22.49% | -13.30% | |||
| Return On Equity (ROE) | -62.55% | 15.40% | -62.37% | -182.73% | -45.13% | |||
| Return On Invested Capital (ROIC) | N/A | 5.33% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 9.18% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | 9.31% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21